News blog

Akers Biosciences Inc

  • BY: Andrew Hore |
  • POSTED: 10/04/2013 |

Akers Diagnostics Inc has received an order for 1.4m CHUBE-branded disposable breath alcohol detectors from its distributor Chubeworkx Guernsey for the French market.

The order is worth $420,000 and takes the total value of orders so far to $1.5m. There was a licence fee of $1m on top of that. Akers will be recognising more than $2m of revenues from this source in 2013. Joint broker Daniel Stewart has increased its 2013 revenues forecast for Akers from $3.5m to $4.5m. This should be enough to push Akers into profit and $500,000 has been penciled-in.

Growth in the sales of PIFA tests has helped to boost revenues. These sales are one-fifth higher so far this year. Costs are being cut and this will also help to move the business into profit.

At 1.43p a share, up 0.2p, Akers is valued at 2.83m. The shares are trading on around 12 times prospective 2013 earnings.

Download the latest AIM Journal from http://www.hubinvest.com/AIMPDFMarch2013_42.pdf

© 2022 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds